Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Vaxcyte, Inc.

Clinical trials sponsored by Vaxcyte, Inc., explained in plain language.

Vaxcyte, Inc. PCVX NASDAQ

A biopharmaceutical company developing vaccines to prevent bacterial infections.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 4 Completed 1
Sort by
  • New vaccine targets group a strep in first human test

    ⭐️ VACCINE ⭐️ Recruiting now

    This early-stage trial tests a new vaccine called VAX-A1 in 80 healthy adults aged 18-40. The vaccine aims to prevent infections caused by Group A Streptococcus bacteria, which can cause strep throat and more serious illnesses. The study focuses on safety and immune response, wit…

    Phase: PHASE1 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️

    Last updated Jun 27, 2026 14:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space